Cash & equivalents decreased 77.4%
Cash & equivalents changed -77.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -77.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -42.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed -25.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -33.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -1348 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +8.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating margin changed -506 basis points from the comparable as-filed period.
Shares outstanding changed -3.3% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Gross margin changed -271 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -16.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed +263 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed +453.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -738 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +7.9% from the comparable as-filed period.
Operating income changed -10.1% from the comparable as-filed period.
Operating cash-flow margin changed -475 basis points from the comparable as-filed period.
Operating cash flow changed -7.6% from the comparable as-filed period.
Net income changed -11.7% from the comparable as-filed period.
Current liabilities changed +12.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cost of revenue changed +14.2% from the comparable as-filed period.
Inventory / revenue changed +55 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -9 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross profit changed +2.4% from the comparable as-filed period.
Research & development changed +1.7% from the comparable as-filed period.
Stock-based compensation changed +1.1% from the comparable as-filed period.
Operating cash flow / net income changed +4.6% from the comparable as-filed period.
R&D / revenue changed -22 basis points from the comparable as-filed period.
Current liabilities changed +18.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -15.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +211 basis points from the comparable as-filed period.
Inventory / revenue changed -384 basis points from the comparable as-filed period.
Working capital / assets changed -333 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Shares outstanding changed -2.3% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Operating income changed +11.2% from the comparable as-filed period.
Gross margin changed +129 basis points from the comparable as-filed period.
Net income changed +13.6% from the comparable as-filed period.
Revenue changed +3.3% from the comparable as-filed period.
Stock-based compensation changed -13.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed -65 basis points from the comparable as-filed period.
Total assets changed +2.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating cash flow changed -2.7% from the comparable as-filed period.
Free-cash-flow margin changed -120 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed -1.1% from the comparable as-filed period.
Working capital changed -7.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -26 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -186 basis points from the comparable as-filed period.
Capital expenditure changed -16.4% from the comparable as-filed period.
Cash & equivalents changed -5.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating cash flow / net income changed -14.3% from the comparable as-filed period.
Inventory changed -2.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +5.8% from the comparable as-filed period.
Research & development changed -4.4% from the comparable as-filed period.
Current assets changed -0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed -27 basis points from the comparable as-filed period.
Cost of revenue changed +0.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.